A three arm phase II chemoprevention trial in adenomatous polyposis coli patients - workstatement no. 65
Ended Definitive Contract Awarded Last action
- Contract number
- 00261199909D261995040
- Awardee
-
The Univeristy Of Texas M.d. Anderson Cancer Center UEI S3GMKS8ELA16 Part of University Of Texas System
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,696,536
Award facts
- Contract value 20% obligated
- $13,481,325.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer
- Pricing
- Cost No Fee
- Place of performance
- Houston, TX 77030, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $67,536 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $500,000 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $589,000 | |
| Supplemental Agreement for work within scope | $247,000 | |
| Supplemental Agreement for work within scope | $500,000 | |
| Original award | $793,000 |
Show all 12
About this award
This is a three-year, $13,481,325.00 definitive contract awarded by the National Cancer Institute (NCI) to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract supports a Phase II chemoprevention clinical trial in patients with adenomatous polyposis coli, a genetic condition that increases cancer risk. The contract does not have a small business set-aside designation. MD Anderson Cancer Center, a comprehensive cancer research and treatment center, has received numerous prime and subcontract awards from federal agencies like the National Institutes of Health, Department of Defense, and Department of Veterans Affairs to support cancer research, prevention, and clinical trials. As the parent organization, the University of Texas System is a large public university system that leverages its broad academic and research capabilities to participate in federal contracts and grants across scientific and technical domains.
Quick answers
Who was awarded contract 00261199909D261995040?
00261199909D261995040 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by National Cancer Institute (National Institutes of Health) on September 15, 1999.
How much is contract 00261199909D261995040 worth?
The government has obligated $2,696,536 on 00261199909D261995040. Its current value, with exercised options, is $13,481,325.
Was contract 00261199909D261995040 competed?
The extent of competition for 00261199909D261995040 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award